103 related articles for article (PubMed ID: 25514067)
1. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.
Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
Clin Transl Sci; 2020 Nov; 13(6):1170-1177. PubMed ID: 32441836
[TBL] [Abstract][Full Text] [Related]
3. Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.
Shi L; Ascher-Svanum H; Chiang YJ; Zhao Y; Fonseca V; Winstead D
BMC Psychiatry; 2009 Dec; 9():80. PubMed ID: 20021664
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.
Daumit GL; Goff DC; Meyer JM; Davis VG; Nasrallah HA; McEvoy JP; Rosenheck R; Davis SM; Hsiao JK; Stroup TS; Lieberman JA
Schizophr Res; 2008 Oct; 105(1-3):175-87. PubMed ID: 18775645
[TBL] [Abstract][Full Text] [Related]
5. Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia.
Brainerd DR; Alexander B; Tague MJ; Lund BC
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767931
[No Abstract] [Full Text] [Related]
6. Olanzapine/samidorphan (Lybalvi) for schizophrenia and bipolar disorder.
Med Lett Drugs Ther; 2021 Nov; 63(1638):191-192. PubMed ID: 35085217
[No Abstract] [Full Text] [Related]
7. Discontinuation of antipsychotics in individuals with first-episode schizophrenia and its association to functional outcomes, hospitalization and death: a register-based nationwide follow-up study.
Stürup AE; Nordentoft M; Jimenez-Solem E; Osler M; Davy JW; Christensen TN; Speyer H; Albert N; Hjorthøj C
Psychol Med; 2023 Aug; 53(11):5033-5041. PubMed ID: 35818718
[TBL] [Abstract][Full Text] [Related]
8. Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics.
Lyu N; Rowan PJ; Abughosh S; Varisco TJ; Lin Y; Chen H
J Child Adolesc Psychopharmacol; 2024 May; 34(4):201-209. PubMed ID: 38407930
[No Abstract] [Full Text] [Related]
9. Antipsychotic therapy during early and late pregnancy. A systematic review.
Gentile S
Schizophr Bull; 2010 May; 36(3):518-44. PubMed ID: 18787227
[TBL] [Abstract][Full Text] [Related]
10. Self-reported reasons for discontinuation or continuation of antipsychotic medication in individuals with first-episode schizophrenia.
Stürup AE; Hjorthøj C; Jensen HD; Melau M; Davy JW; Nordentoft M; Albert N
Early Interv Psychiatry; 2023 Oct; 17(10):974-983. PubMed ID: 36693651
[TBL] [Abstract][Full Text] [Related]
11. Association between Serum Lipids and Antipsychotic Response in Schizophrenia.
Kim DD; Barr AM; Fredrikson DH; Honer WG; Procyshyn RM
Curr Neuropharmacol; 2019; 17(9):852-860. PubMed ID: 30819084
[TBL] [Abstract][Full Text] [Related]
12. Secondary effects of antipsychotics: women at greater risk than men.
Seeman MV
Schizophr Bull; 2009 Sep; 35(5):937-48. PubMed ID: 18400811
[TBL] [Abstract][Full Text] [Related]
13. No gender differences in the pharmacological emergency treatment of schizophrenia: results of a 21-year observation.
Edlinger M; Brettbacher S; Schurr T; Yalcin-Siedentopf N; Hofer A
Int Clin Psychopharmacol; 2024 Jan; 39(1):36-41. PubMed ID: 37555960
[TBL] [Abstract][Full Text] [Related]
14. Predictors and patterns of weight gain during treatment for tuberculosis in the United States of America.
Phan MN; Guy ES; Nickson RN; Kao CC
Int J Infect Dis; 2016 Dec; 53():1-5. PubMed ID: 27693292
[TBL] [Abstract][Full Text] [Related]
15. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.
Domecq JP; Prutsky G; Leppin A; Sonbol MB; Altayar O; Undavalli C; Wang Z; Elraiyah T; Brito JP; Mauck KF; Lababidi MH; Prokop LJ; Asi N; Wei J; Fidahussein S; Montori VM; Murad MH
J Clin Endocrinol Metab; 2015 Feb; 100(2):363-70. PubMed ID: 25590213
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment.
Wani RA; Dar MA; Margoob MA; Rather YH; Haq I; Shah MS
J Neurosci Rural Pract; 2015 Jan; 6(1):17-22. PubMed ID: 25552846
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
Wu YH; Lai CY; Chang YS
Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
[TBL] [Abstract][Full Text] [Related]
18. Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.
Margari L; Matera E; Petruzzelli MG; Simone M; Lamanna AL; Pastore A; Palmieri VO; Margari F
Int Clin Psychopharmacol; 2015 Mar; 30(2):103-8. PubMed ID: 25514607
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
Baser O; Xie L; Pesa J; Durkin M
J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
[TBL] [Abstract][Full Text] [Related]
20. Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.
Jensen KG; Juul K; Fink-Jensen A; Correll CU; Pagsberg AK
J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):25-36. PubMed ID: 25524787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
